Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02867124 · ClinicalTrials.gov registry record · Phase 3
Long-acting Naltrexone for Pre-release Prisoners
A Phase 3 study of Opiate Addiction, sponsored by Friends Research Institute.
- Completed
- Registry status
- Phase 3
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT02867124 is a Phase 3 study of Opiate Addiction that has completed, run by Friends Research Institute. The registered enrollment target is 240 participants, above the 137-participant average among 5 other Opiate Addiction trials with a reported enrollment target (75% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02867124, a Phase 3 study of Opiate Addiction, has completed, sponsored by Friends Research Institute.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposed five-year study will focus on whether the addition of providing XR-NTX treatment at a patients' place of residence will increase adherence and thus efficacy of the medication.Following initial screening, informed consent, and medical examination, pre-release prisoners at each facility will be block randomized (N=240) within gender to either: Condition 1. XR-NTX-OTx (n=120): One injection of XR-NTX in prison, followed by six monthly injections post-release in the community at an opioid treatment program; or Condition 2. XR-NTX+MMTx (n=120): One injection of XR-NTX in prison, followed by six monthly injections post-release in the community at the patient's place of residence.
Conditions Studied
Interventions
- DRUG XR-NTX
- OTHER place of residence
- OTHER opioid treatment program
Study Locations (1)
Maryland
- Maryland Department of Public Safety and Correctional Services - Towson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2026-01-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02867124
The ClinicalTrials.gov registry entry for NCT02867124 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 137-participant average among 5 other Opiate Addiction trials with a reported enrollment target (75% higher). The listed sponsor is Friends Research Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opiate Addiction appearing as the primary indexed condition, and to 3 interventions - of which XR-NTX is the first listed.
NCT02867124 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02867124 about?
NCT02867124 is a clinical study titled "Long-acting Naltrexone for Pre-release Prisoners". This proposed five-year study will focus on whether the addition of providing XR-NTX treatment at a patients' place of residence will increase adherence and thus efficacy of the medication.Following initial screening, informed consent, and medical examination, pre-release prisoners at each facility ...
What is the current status of trial NCT02867124?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 2017-01-01. Estimated completion is 2026-01-01.
What conditions does trial NCT02867124 study?
This clinical trial studies the following conditions: Opiate Addiction.
What interventions are being tested in trial NCT02867124?
The interventions under investigation include: XR-NTX (DRUG), place of residence (OTHER), opioid treatment program (OTHER).
Who is sponsoring clinical trial NCT02867124?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02867124 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opiate Addiction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Treatment for Opioid Dependence and Anxiety Disorders
COMPLETED · NA
-
Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site
COMPLETED · Phase 2
-
HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)
COMPLETED
-
Study of Opioid Use After Lumbar and Cervical Spine Surgery
COMPLETED · NA
-
Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM)
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.